HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
